BioSpace News Archive

Press Releases

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)

December 16, 2024
·
15 min read
Press Releases

Viridian Therapeutics to Webcast Veligrotug Phase 3 THRIVE-2 Topline Results on December 16, 2024

December 16, 2024
·
4 min read
Press Releases

Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement

December 16, 2024
·
7 min read
Press Releases

FDA Approves New Treatment for Congenital Adrenal Hyperplasia

December 16, 2024
·
3 min read
Press Releases

Neurocrine Biosciences Announces FDA Approval of CRENESSITY™ (crinecerfont), a First-in-Class Treatment for Children and Adults With Classic Congenital Adrenal Hyperplasia

December 16, 2024
·
15 min read
Press Releases

Quantum Biopharma Announces Closing of First Tranche

December 16, 2024
·
5 min read
Press Releases

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

December 16, 2024
·
2 min read
Press Releases

Pharming announces public cash offer to the shareholders of Abliva AB

December 16, 2024
·
10 min read
Press Releases

Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union

December 16, 2024
·
11 min read
Press Releases

Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China

December 16, 2024
·
8 min read